Stockreport

ArriVent Appoints Brent S. Rice as Chief Commercial Officer

ArriVent BioPharma, Inc.  (AVBP) 
PDF NEWTOWN SQUARE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerati [Read more]